S L Neuhausen
Overview
Explore the profile of S L Neuhausen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
1867
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adamson A, Ding Y, Steele L, Leong L, Morgan R, Wakabayashi M, et al.
J Ovarian Res
. 2023 Jul;
16(1):141.
PMID: 37460928
Background: High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with...
2.
Adamson A, Ding Y, Steele L, Leong L, Morgan R, Wakabayashi M, et al.
Res Sq
. 2023 Mar;
PMID: 36865331
High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-free...
3.
Metcalfe K, Lubinski J, Gronwald J, Huzarski T, McCuaig J, Lynch H, et al.
Clin Genet
. 2017 Dec;
93(5):1063-1068.
PMID: 29206279
The objective of this study was to estimate the lifetime risk of breast cancer in women with a BRCA1 or BRCA2 mutation with and without at least 1 first-degree relative...
4.
Foo T, Tischkowitz M, Simhadri S, Boshari T, Zayed N, Burke K, et al.
Oncogene
. 2017 Mar;
36(29):4161-4170.
PMID: 28319063
The major breast cancer suppressor proteins BRCA1 and BRCA2 play essential roles in homologous recombination (HR)-mediated DNA repair, which is thought to be critical for tumor suppression. The two BRCA...
5.
Narod S, Tung N, Lubinski J, Huzarski T, Robson M, Lynch H, et al.
Curr Oncol
. 2014 Apr;
21(2):64-8.
PMID: 24764694
Background: The risk of breast cancer in carriers of BRCA1 and BRCA2 mutations is influenced by factors other than the genetic mutation itself. Modifying factors include a woman's reproductive history...
6.
Phelan C, Iqbal J, Lynch H, Lubinski J, Gronwald J, Moller P, et al.
Br J Cancer
. 2013 Dec;
110(2):530-4.
PMID: 24292448
Background: The BRCA1 and BRCA2 genes confer increased susceptibility to breast and ovarian cancer and to a spectrum of other cancers. There is controversy regarding the risk of colorectal cancer...
7.
Neuhausen S
Theor Appl Genet
. 2013 Nov;
83(3):379-84.
PMID: 24202522
The objectives of this study were to assess the degree of restriction fragment length polymorphism (RFLP) in Cucumis melo and to determine interrelationships among cultivated varieties. Initial screening of a...
8.
Iqbal J, Ragone A, Lubinski J, Lynch H, Moller P, Ghadirian P, et al.
Br J Cancer
. 2012 Oct;
107(12):2005-9.
PMID: 23099806
Background: Germline mutations in BRCA1 and BRCA2 predispose to pancreatic cancer. We estimated the incidence of pancreatic cancer in a cohort of female carriers of BRCA1 and BRCA2 mutation. We...
9.
Park D, Lesueur F, Nguyen-Dumont T, Pertesi M, Odefrey F, Hammet F, et al.
Am J Hum Genet
. 2012 Apr;
90(4):734-9.
PMID: 22464251
An exome-sequencing study of families with multiple breast-cancer-affected individuals identified two families with XRCC2 mutations, one with a protein-truncating mutation and one with a probably deleterious missense mutation. We performed...
10.
Ratner E, Keane F, Lindner R, Tassi R, Paranjape T, Glasgow M, et al.
Oncogene
. 2011 Dec;
31(42):4559-66.
PMID: 22139083
Germline variants in the 3' untranslated region (3'UTR) of cancer genes disrupting microRNA (miRNA) regulation have recently been associated with cancer risk. A variant in the 3'UTR of the KRAS...